|
IT1291892B1
(it)
*
|
1997-04-24 |
1999-01-21 |
Alessandro Lambiase |
Uso del nerve growth factor nella conservazione di cornee in coltura, nella produzione di tessuti corneali e congiuntivali in vitro e nella
|
|
ES2206965T3
(es)
|
1997-07-29 |
2004-05-16 |
Alcon Laboratories, Inc. |
Composiciones oftalmicas que contienen polimeros de galactomanana y borato.
|
|
IT1305294B1
(it)
|
1999-01-29 |
2001-05-04 |
Alessandro Lambiase |
Uso del nerve growth factor nella terapia di patologie a carico deitessuti intraoculari.
|
|
WO2000051619A1
(en)
|
1999-03-01 |
2000-09-08 |
Vista Scientific Llc |
Mucin containing ophthalmic preparations
|
|
AU2002230504A1
(en)
|
2000-12-20 |
2002-07-01 |
Alcon Universal Ltd. |
Ophthalmic irrigating solution adapted for use in lasik surgery
|
|
AU2002232437A1
(en)
|
2000-12-20 |
2002-07-01 |
Alcon Universal Ltd. |
Ophthalmic lubricating solution adapted for use in lasik surgery
|
|
US7544348B2
(en)
*
|
2001-02-15 |
2009-06-09 |
Access Pharmaceuticals, Inc. |
Liquid formulations for the prevention and treatment of mucosal diseases and disorders
|
|
EP1997478B1
(en)
*
|
2001-02-15 |
2013-09-04 |
Access Pharmaceuticals, Inc. |
Liquid formulations for the prevention and treatment of mucosal diseases and disorders
|
|
US6465506B2
(en)
*
|
2001-02-22 |
2002-10-15 |
Ophthalmic Research Associates, Inc. |
Instillation techniques for ophthalmic agents to enhance treatment effect
|
|
CN1522161A
(zh)
|
2001-06-29 |
2004-08-18 |
�Ȱ�ά����ķ�ɷݹ�˾ |
批量高压灭菌方法
|
|
EP2213308A1
(en)
*
|
2001-08-10 |
2010-08-04 |
Toray Industries Inc. |
Eyedrop comprising agar
|
|
US20040220089A1
(en)
*
|
2001-10-03 |
2004-11-04 |
Ellis Edward J. |
Ophthalmic preparation containing glycoprotein
|
|
US20040214754A1
(en)
*
|
2001-10-03 |
2004-10-28 |
Ellis Edward J. |
Ophthalmic preparation containing glycomacropeptide
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
EP2316459B1
(en)
|
2002-07-29 |
2013-11-06 |
Rigel Pharmaceuticals, Inc. |
2,4-pyrimidinediamine compounds for use in methods of treating or preventing autoimmune diseases
|
|
US6984628B2
(en)
*
|
2003-07-15 |
2006-01-10 |
Allergan, Inc. |
Ophthalmic compositions comprising trefoil factor family peptides
|
|
ATE506953T1
(de)
|
2003-08-07 |
2011-05-15 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidindiamin-verbindungen und verwendungen als antiproliferative mittel
|
|
PL1654002T5
(pl)
*
|
2003-08-07 |
2014-06-30 |
Allergan Inc |
Kompozycje do dostarczania środków terapeutycznych do oczu
|
|
WO2005039640A1
(en)
*
|
2003-10-03 |
2005-05-06 |
Allergan Inc. |
Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump inhibitor prodrugs
|
|
CA2549737A1
(en)
*
|
2003-11-10 |
2005-05-26 |
Toray Industries, Inc. |
Polysaccharide-containing composition and tear film stabilizing ophthalmic solution
|
|
US20050210732A1
(en)
*
|
2004-03-26 |
2005-09-29 |
Guerin John W |
Crank bait tail
|
|
JP4395016B2
(ja)
*
|
2004-06-29 |
2010-01-06 |
日清オイリオグループ株式会社 |
ゲル状吸水用組成物
|
|
DE602006006424D1
(de)
*
|
2005-02-09 |
2009-06-04 |
Safilens S R L |
Ackung zur aufbewahrung und pflege einer kontaktlinse
|
|
PT1698630E
(pt)
|
2005-03-03 |
2014-09-15 |
Alfa Wassermann Spa |
Novas formas polimorfas de rifaximina, processos para a sua produção e a sua utilização nas preparações medicinais
|
|
ITBO20050388A1
(it)
*
|
2005-06-06 |
2006-12-07 |
Alfa Wassermann Spa |
Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
|
|
ITRM20050447A1
(it)
*
|
2005-08-19 |
2007-02-20 |
Anabasis S R L |
Uso del nerve growth factor in collirio nella terapia di patologie del sistema nervoso centrale, quali la malattia di alzheimer e il morbo di parkinson.
|
|
JP2009528295A
(ja)
|
2006-02-24 |
2009-08-06 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
Ｊａｋ経路の阻害のための組成物および方法
|
|
JP5134778B2
(ja)
*
|
2006-03-10 |
2013-01-30 |
日清オイリオグループ株式会社 |
ゲル組成物及び該ゲル組成物を使用したパック化粧料
|
|
DK2078026T3
(da)
|
2006-11-21 |
2012-04-30 |
Rigel Pharmaceuticals Inc |
Prodrug-salte af 2, 4-pyrimidinediamine-forbindelser og anvendelser deraf
|
|
ITRM20070510A1
(it)
*
|
2007-10-02 |
2009-04-03 |
Rmfa Trading S A |
Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.
|
|
GB0719969D0
(en)
|
2007-10-12 |
2007-11-21 |
Cambridge Entpr Ltd |
Substance monitoring and control in human or animal bodies
|
|
WO2009105140A2
(en)
|
2007-12-11 |
2009-08-27 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
|
|
US9192571B2
(en)
*
|
2008-03-03 |
2015-11-24 |
Allergan, Inc. |
Ketorolac tromethamine compositions for treating or preventing ocular pain
|
|
US7842714B2
(en)
|
2008-03-03 |
2010-11-30 |
Allergan, Inc. |
Ketorolac tromethamine compositions for treating ocular pain
|
|
JP5815411B2
(ja)
|
2008-12-30 |
2015-11-17 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
ピリミジンジアミンキナーゼ阻害剤
|
|
ES2473584T3
(es)
|
2009-01-23 |
2014-07-07 |
Rigel Pharmaceuticals, Inc. |
Composiciones y métodos para la inhibición de la ruta de JAK
|
|
CN104523661A
(zh)
|
2009-02-06 |
2015-04-22 |
南加利福尼亚大学 |
含有单萜的治疗组合物
|
|
US20110028503A1
(en)
|
2009-07-28 |
2011-02-03 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
IT1396607B1
(it)
*
|
2009-11-16 |
2012-12-14 |
Hmfra Hungary Ltd Liability Company |
Preparazioni oftalmiche a base di bdnf (brain-derived neurotrophic factor) e loro uso.
|
|
IT1397132B1
(it)
|
2009-12-01 |
2013-01-04 |
Alfa Wassermann Spa |
Composizioni comprendenti antiinfiammatori non steroidei.
|
|
CN104744215B
(zh)
|
2010-03-03 |
2019-03-15 |
尼昂克技术公司 |
包含单萜的药物组合物
|
|
KR101379370B1
(ko)
|
2010-04-24 |
2014-03-28 |
비아멧 파마슈티컬즈, 인코포레이티드 |
금속효소 억제제 화합물
|
|
CA2800383C
(en)
|
2010-05-24 |
2019-06-25 |
Indena S.P.A. |
Tamarind seed polysaccharide for use in the treatment of inflammatory diseases
|
|
RU2571063C2
(ru)
|
2010-05-24 |
2015-12-20 |
Индена С.П.А. |
Полисахарид семени тамаринда для применения в лечении микробных инфекций
|
|
JP5620168B2
(ja)
*
|
2010-06-30 |
2014-11-05 |
Ｄｓｐ五協フード＆ケミカル株式会社 |
キシログルカン−カチオン複合体及びそれを含有する安定化組成物
|
|
SI2593119T1
(sl)
*
|
2010-07-12 |
2016-04-29 |
Zambon S.P.A. |
Polisaharidni polimer iz semen drevesa tamarinda za uporabo v zdravljenju suhega kašlja
|
|
MX347331B
(es)
|
2010-07-28 |
2017-04-21 |
Rigel Pharmaceuticals Inc |
Composiciones y metodos para inhibicion de la via jak.
|
|
CN110464718A
(zh)
|
2010-08-27 |
2019-11-19 |
尼昂克技术公司 |
包含poh衍生物的药物组合物
|
|
US20160038600A1
(en)
|
2012-08-03 |
2016-02-11 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising poh derivatives
|
|
CA2816088A1
(en)
|
2010-10-28 |
2012-05-03 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitor compounds
|
|
KR20180039185A
(ko)
|
2010-11-13 |
2018-04-17 |
이노크린 파마슈티컬즈, 인크. |
금속효소 억제제 화합물
|
|
CN103517892B
(zh)
|
2010-12-17 |
2016-01-27 |
尼昂克技术公司 |
使用异紫苏醇的方法和装置
|
|
EP2678297A2
(en)
|
2011-02-25 |
2014-01-01 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Chrysophaentin analogs that inhibit ftsz protein
|
|
ITMI20110583A1
(it)
|
2011-04-08 |
2012-10-09 |
Hmfra Hungary Ltd Liability Company |
Preparazioni oftalmiche a base di pacap (pituitary adenylate cyclase activating polypeptide) al fine di ripristinare la normale funzione visiva nel glaucoma in fase precoce
|
|
RU2463022C1
(ru)
*
|
2011-04-19 |
2012-10-10 |
Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" |
Способ лечения больных с синдромом "сухого глаза"
|
|
US8883497B2
(en)
|
2011-04-28 |
2014-11-11 |
University Of Southern California |
Human myeloid derived suppressor cell cancer markers
|
|
WO2012177635A1
(en)
|
2011-06-19 |
2012-12-27 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitor compounds
|
|
WO2012177603A2
(en)
|
2011-06-19 |
2012-12-27 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitor compounds
|
|
CA2838916C
(en)
|
2011-06-23 |
2020-08-11 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitor compounds
|
|
SI2741754T1
(sl)
*
|
2011-08-12 |
2015-09-30 |
Zambon S.P.A. |
Uporaba polisaharidnega polimera iz semen drevesa tamarinda v zaščiti proti s tobakom povezanih poškodb
|
|
JP6376550B2
(ja)
*
|
2011-09-07 |
2018-08-22 |
千寿製薬株式会社 |
水性液剤の粘度低下抑制方法
|
|
WO2013046059A2
(en)
*
|
2011-09-27 |
2013-04-04 |
Sykora Robert C |
Methods and compositions for tamarind-based ocular disease treatment in combination with trehalose
|
|
US9309273B2
(en)
|
2011-12-11 |
2016-04-12 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitor compounds
|
|
ES2774267T3
(es)
|
2012-01-20 |
2020-07-20 |
Mycovia Pharmaceuticals Inc |
Compuestos inhibidores de metaloenzimas
|
|
JP6231548B2
(ja)
|
2012-03-23 |
2017-11-15 |
マテオン セラピューティクス， インコーポレイテッド |
カテプシンの阻害のための組成物および方法
|
|
US20130310340A1
(en)
|
2012-05-16 |
2013-11-21 |
Rigel Pharmaceuticals, Inc. |
Method of treating muscular degradation
|
|
US20160166701A1
(en)
*
|
2013-07-05 |
2016-06-16 |
Therakine Biodelivery Gmbh |
Delivery composition for topical applications and injections and ophthalmic formulations, methods for manufacturing thereof, and methods for delivery of a drug-delivery composition
|
|
EP2883931A1
(en)
*
|
2013-12-12 |
2015-06-17 |
Omya International AG |
Improved gel stability
|
|
ES2675305T3
(es)
|
2014-04-15 |
2018-07-10 |
Novintethical Pharma Sa |
Composiciones a base de xiloglucano y proteínas para el tratamiento de trastornos intestinales
|
|
US11623008B2
(en)
*
|
2014-08-20 |
2023-04-11 |
Professional Compounding Centers Of America |
Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
|
|
AU2016219257B2
(en)
|
2015-02-12 |
2020-06-25 |
University Of Southern California |
Pharmaceutical compositions comprising perillyl alcohol derivatives
|
|
EP3103438B1
(en)
|
2015-06-11 |
2018-11-14 |
Novintethical Pharma SA |
Topical nasal compositions containing xyloglucans for use as decongestans
|
|
SG10201913468YA
(en)
*
|
2015-07-13 |
2020-03-30 |
Tohoku Techno Arch Co Ltd |
Composition for optic nerve protection
|
|
JP6994454B2
(ja)
|
2015-08-04 |
2022-01-14 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
ベンズアゾール化合物ならびに該化合物の作製方法および使用方法
|
|
WO2017025983A1
(en)
|
2015-08-07 |
2017-02-16 |
Council Of Scientific & Industrial Research |
A lubricant formulation of carbamoylethyl katira and a process for preparation thereof
|
|
MX2018008105A
(es)
|
2015-12-30 |
2018-11-12 |
Vps 3 Inc |
Compuestos inhibidores de metaloenzima.
|
|
WO2018005356A1
(en)
|
2016-06-27 |
2018-01-04 |
Rigel Pharmaceuticals, Inc. |
2,4-diamino-pyrimidine compounds and method for making and using the compounds
|
|
CN110099899B
(zh)
|
2016-10-26 |
2024-01-02 |
里格尔药品股份有限公司 |
用作irak抑制剂的噁唑衍生物及其制备方法
|
|
WO2018081294A1
(en)
|
2016-10-26 |
2018-05-03 |
Rigel Pharmaceuticals, Inc. |
Pyrazole amide compounds as irak inhibitors
|
|
US10858305B2
(en)
|
2016-11-30 |
2020-12-08 |
Neonc Technologies, Inc. |
Perillyl alcohol-3-bromopyruvate conjugate and methods of treating cancer
|
|
EP3562306A4
(en)
|
2016-12-29 |
2020-06-24 |
Selenity Therapeutics (Bermuda), Ltd. |
METALLOENZYME INHIBITOR COMPOUNDS
|
|
AU2017387033B2
(en)
|
2016-12-29 |
2024-02-01 |
Ji Xing Pharmaceuticals Hong Kong Limited |
Metalloenzyme inhibitor compounds
|
|
JP7167069B2
(ja)
|
2017-06-29 |
2022-11-08 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
キナーゼ阻害剤ならびに作製および使用のための方法
|
|
US11129862B2
(en)
*
|
2017-08-30 |
2021-09-28 |
Johnson & Johnson Consumer Inc. |
Ophthalmic compositions
|
|
US20210292410A1
(en)
|
2017-12-07 |
2021-09-23 |
Morphosys Ag |
Treatment paradigm for an anti-cd19 antibody and venetoclax combination treatment
|
|
BR112020016074A2
(pt)
|
2018-02-08 |
2020-12-08 |
Neonc Technologies, Inc |
Métodos de permeabilização da barreira hematoencefálica
|
|
DK3788044T3
(da)
|
2018-05-03 |
2023-10-02 |
Rigel Pharmaceuticals Inc |
RIP1-hæmmende forbindelser og fremgangsmåder til fremstilling og anvendelse heraf
|
|
FI3788045T3
(fi)
|
2018-05-03 |
2023-06-28 |
Rigel Pharmaceuticals Inc |
RIP1-inhibitorisia yhdisteitä ja samojen valmistus- ja käyttömenetelmiä
|
|
US20220000880A1
(en)
|
2018-11-01 |
2022-01-06 |
Rigel Pharmaceuticals, Inc. |
Method and composition embodiments for treating acute myeloid leukemia
|
|
US20200377518A1
(en)
|
2019-05-29 |
2020-12-03 |
Rigel Pharmaceuticals, Inc. |
Method of preventing and treating thrombosis
|
|
MX2022001596A
(es)
|
2019-08-08 |
2022-03-11 |
Rigel Pharmaceuticals Inc |
Compuestos y metodos para tratar sindrome de liberacion de citocinas.
|
|
EP4013420B1
(en)
|
2019-08-14 |
2023-11-01 |
Rigel Pharmaceuticals, Inc. |
Method of blocking or ameliorating cytokine release syndrome
|
|
JP2022545542A
(ja)
|
2019-08-30 |
2022-10-27 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
ピラゾール化合物、その製剤並びに化合物及び／又は製剤を使用する方法
|
|
MX2022002717A
(es)
|
2019-09-06 |
2022-08-10 |
Rigel Pharmaceuticals Inc |
Compuestos inhibidores de rip1 y metodos para prepararlos y usarlos.
|
|
KR20220042431A
(ko)
|
2019-09-06 |
2022-04-05 |
리겔 파마슈티칼스, 인크. |
헤테로시클릭 rip1 키나제 억제제
|
|
CN115298184A
(zh)
|
2019-11-07 |
2022-11-04 |
里格尔药品股份有限公司 |
杂环rip1抑制化合物
|
|
US20220288047A1
(en)
|
2021-03-03 |
2022-09-15 |
Rigel Pharmaceuticals, Inc. |
Method for treating a disease or condition using a pyrazole compound or formulation thereof
|
|
TW202300490A
(zh)
|
2021-03-11 |
2023-01-01 |
美商雷傑製藥公司 |
雜環rip1激酶抑制劑
|
|
TW202346291A
(zh)
|
2022-03-23 |
2023-12-01 |
美商雷傑製藥公司 |
作為ｉｒａｋ抑制劑的嘧啶—２—基—吡唑化合物
|
|
US20230312568A1
(en)
|
2022-03-31 |
2023-10-05 |
Rigel Pharmaceuticals, Inc. |
Tricyclic irak inhibitors
|